Life Edit Therapeutics Appoints Joy A. Cavagnaro to Its Scientific Advisory Board
MORRISVILLE, N.C.–(BUSINESS WIRE)–#geneediting–Life Edit Therapeutics Inc., an ElevateBio company focused on next-generation genome editing technologies and therapeutics, today announced the appointment of Joy A. Cavagnaro, Ph.D., DABT, Fellow ATS, RAC, FRAPS, to its Scientific Advisory Board (SAB). Dr. Cavagnaro is an internationally recognized expert in science-based regulatory strategies and translation of research to preclinical and … [Read more…]
